ASSOCIATION OF LICEN PLANUS WITH HEPATITIS-C IN SOUTHERN PUNJAB POPULATION

Main Article Content

Sahrish Liaqat
Muhammad Ali Hashim
Muhammad Mashood Riaz
Roshaan Mazhar
Shahzad Nasir
Muhammad Abi Waqas

Keywords

Lichen planus, Hepatitis C virus, Oral lesions, Extrahepatic manifestation, Southern Punjab

Abstract

Lichen planus (LP) is a chronic mucocutaneous disorder that has been increasingly associated with hepatitis C virus (HCV) infection. The relationship between these conditions is of particular clinical importance in Pakistan, where HCV prevalence is among the highest globally.


Objective: To evaluate the correlation of lichen planus with hepatitis C in patients reporting to a tertiary care dental institute in Southern Punjab.


Material and Method: This cross-sectional observational study took place at the Department of Oral Medicine, Nishtar Institute of Dentistry, Multan, under the guidance of Dr. Sahrish Liaqat between January 2025 and June 2025. One hundred and fifty LP patients clinically and histologically confirmed were recruited. Demographic and clinical characteristics were noted. Anti-HCV antibodies were detected in venous blood samples with ELISA, and PCR was done to demonstrate an active infection. Data were studied to determine the rate and connection between LP and HCV.


Results: Among 150 patients with LP, 54 (36%) were anti-HCV-positive, and PCR confirmed 47 (31.3%) with active infection. The most common was oral presentation (68%) with an increased incidence of HCV positivity (40.2%) as compared to cutaneous (23.8%). Patients in the middle age (31 to 50 years) had the highest HCV positivity (39.2%). Though females were more affected, the difference in gender was not statistically significant.


Conclusion: There is a close correlation between lichen planus and hepatitis C infection, especially in oral cases of lichen planus. Routine screening of HCV is advisable in patients with LP to help diagnose its presence early and adopt comprehensive measures in its management.

Abstract 165 | PDF Downloads 21

References

1. Iqbal M. Frequency of positive anti hepatitis C virus antibodies among lichen planus patients.
2. Khan N, Abro HA, Ahmed S, Shaikh RH, Muneer A. Frequency of thrombocytopenia in chronic hepatitis C. Indus J Biosci Res. 2025 Jun 30;3(6):771-5.
3. García-Pola M, Rodríguez-Fonseca L, Suárez-Fernández C, Sanjuán-Pardavila R, Seoane-Romero J, Rodríguez-López S. Bidirectional association between lichen planus and hepatitis C—an update systematic review and meta-analysis. J Clin Med. 2023 Sep 5;12(18):5777.
4. Pitak-Arnnop P, Subbalekha K, Sirintawat N, Tangmanee C, Auychai P, Muangchan C, et al. Are oral lichen planus patients at high risk of hepatitis C? A case-control study. J Stomatol Oral Maxillofac Surg. 2022 Jun 1;123(3):e37-42.
5. Wang JH, Hung SJ. Lichen planus associated with hepatitis B, hepatitis C, and liver cirrhosis in a nationwide cohort study. J Am Acad Dermatol. 2021 Apr 1;84(4):1085-6.
6. Shree MR, Sree G, Lakshmi PV, Devi EN, Sahithi C. A study of clinical presentation of lichen planus and association between lichen planus and hepatitis C infection in territory care hospital. Int J Acad Med Pharm. 2024;6(1):944-9.
7. Khryanin AA, Sokolovskaya A, Bocharova VK. Lichen planus associated with viral hepatitis C: clinical case. Iran J Colorectal Res. 2022 Sep 1;10(3):110-4.
8. Kefeli A. Is the frequency of hepatitis B virus and hepatitis C virus infection increased in patients with lichen planus? EC Gastroenterol Dig Syst. 2021;8:48-53.
9. Rotaru DI, Chisnoiu RM, Kui AI, Bolboacă SD, Chisnoiu AM. The influence of hepatitis C virus infection on oral health-related quality of life in patients with oral lichen planus. Int J Environ Res Public Health. 2021 Sep 6;18(17):9382.
10. Adnane S, Mahad C, Haitami S, Yahya IB. Hepatitis C virus infection and oral lichen planus: A controversial association. Adv Oral Maxillofac Surg. 2022 Apr 1;6:100271.
11. Sharma A, Bhandari A, Chatterjee D, Narang T. Atrophic lichen planus post‐COVID vaccination in a hepatitis C positive individual. Dermatol Ther. 2022 Sep 29:e15829.
12. Di Stasio D, Lucchese A, Romano A, Adinolfi LE, Serpico R, Marrone A. The clinical impact of direct-acting antiviral treatment on patients affected by hepatitis C virus-related oral lichen planus: A cohort study. Clin Oral Investig. 2022 Aug;26(8):5409-17.
13. González-Moles MÁ, de Porras-Carrique T, Ramos-García P. Association of oral lichen planus with hepatic disorders and hepatocellular carcinoma: Systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal. 2023 Feb 18;28(3):e229.
14. Nagao Y, Tsuji M. Effects of hepatitis C virus elimination by direct‐acting antiviral agents on the occurrence of oral lichen planus and periodontal pathogen load: A preliminary report. Int J Dent. 2021;2021:8925879.
15. Nagao Y, Tsuji M. Effects of hepatitis C virus elimination by direct‐acting antiviral agents on the occurrence of oral lichen planus and periodontal pathogen load: A preliminary report. Int J Dent. 2021;2021:8925879.
16. Avriyanti E, Ala NM, Sutedja E, Tsaqilah L, Firdaus CP, Sutedja EK, et al. Lichen planus pigmentosus as a cutaneous extrahepatic manifestation of chronic hepatitis C virus infection: a case report. Int Med Case Rep J. 2025 Dec 31:577-83.
17. Ma SH, Tai YH, Dai YX, Chang YT, Chen TJ, Chen MH. Association between hepatitis C virus infection and subsequent chronic inflammatory skin disease. J Dermatol. 2021 Dec;48(12):1884-91.
18. Barajas L, Steuer M, Amerson E. Variable clinical course of lichen planus following hepatitis C cure with direct-acting antivirals: a case series and literature review. J Am Acad Dermatol. 2021 Apr 1;84(4):1142-6.